Myriad offers three genetic tests to those who are pregnant or are considering ... in 99.9% of 1,029 pregnant women between 7-37 weeks gestational age. In a 2021 laboratory test, SneakPeek accurately ...

Colossal Biosciences CEO and co-founder Ben Lamm gets the Jurassic Park comparison. When your company is trying to bring back ...

Colossal Biosciences CEO and co-founder Ben Lamm gets the "Jurassic Park" comparison. When your company is trying to bring back the woolly mammoth, it’s only natural that people compare it ...

Building a multi-trillion dollar economy. Part 2 of 2 . As a matter of important background, the industrial possibilities ...

Piper Sandler analyst David Westenberg lowered the firm’s price target on Myriad Genetics (MYGN) to $14 from $24 and keeps a Neutral rating on ...

The study found that Prequel ® Prenatal Screen with AMPLIFY™ technology enables reliable results as early as eight-weeks’ gestation. Typically, prenatal cell-free DNA (pcfDNA) screening is offered ...

In this article, we are going to take a look at where Myriad Genetics, Inc. (NASDAQ:MYGN) stands against Larry Robbins' other long-term stock picks. Larry Robbins is an American hedge fund manager ...

We recently compiled a list of the Billionaire Larry Robbins’ Long-Term Stock Picks. In this article, we are going to take a ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 3.75% of ...

Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced it will unveil groundbreaking research at ...

Research analysts at Leerink Partnrs boosted their FY2024 EPS estimates for Myriad Genetics in a note issued to investors on Tuesday, January 21st. Leerink Partnrs analyst P. Souda now forecasts that ...